+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Total Prostate Specific Antigen Assay Kit Market - Global Forecast 2026-2032- Product Image
Total Prostate Specific Antigen Assay Kit Market - Global Forecast 2026-2032- Product Image
Sale

Total Prostate Specific Antigen Assay Kit Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6081718
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Total Prostate Specific Antigen Assay Kit Market is projected to reach USD 2.01 Billion in 2026. It is expected to continue growing at a CAGR of 6.59%, reaching USD 2.96 Billion by 2032.

Total Prostate-Specific Antigen Assay Kits: Executive Summary

Total prostate-specific antigen (PSA) assay kits support laboratory measurement of PSA in human blood and are used alongside clinical assessment, patient history, and other diagnostic procedures. Their relevance is shaped by prostate-health screening practices, diagnostic follow-up, laboratory infrastructure, reimbursement policies, and demand for standardized, reliable testing. Interpretation should remain clinically contextual because PSA results can be influenced by age, prostate conditions, medications, and recent procedures.

Diagnostic Pathways Are Becoming More Integrated and Quality-Focused

The landscape is shifting from isolated biomarker testing toward integrated diagnostic pathways that combine PSA measurement with digital records, risk assessment, imaging, and confirmatory procedures. Laboratories are placing greater emphasis on analytical sensitivity, reproducibility, calibration, quality controls, workflow automation, and connectivity with laboratory information systems. At the same time, policymakers and clinicians continue to balance earlier detection with the risk of unnecessary investigations, making appropriate-use guidance and shared decision-making increasingly important.

Artificial Intelligence Strengthens Interpretation, Workflow, and Quality Management

Artificial intelligence can support PSA testing by identifying abnormal trends in longitudinal records, prioritizing follow-up, assisting laboratory quality monitoring, and integrating PSA values with demographic, clinical, imaging, and pathology information. Its value depends on representative training data, transparent validation, interoperability, cybersecurity, and safeguards against automation bias. AI should augment-not replace-clinical judgment, particularly where screening decisions and biopsy referrals carry meaningful benefits and risks.

Regional Insights: Infrastructure and Access Shape Adoption

North America is characterized by mature laboratory networks, established clinical pathways, and strong attention to guideline alignment and reimbursement. Europe combines advanced diagnostics with varied national screening policies, procurement structures, and regulatory requirements. Asia-Pacific presents wide differences in laboratory capacity, urban access, and public-health priorities, while also emphasizing automation and expanding diagnostic availability. Latin America is shaped by unequal access, centralized testing in some systems, and the need for affordable, dependable workflows. The Middle East is investing in specialized healthcare capacity, with adoption influenced by public-sector programs and private laboratory networks. Africa remains highly heterogeneous, making decentralized access, supply reliability, workforce training, and quality assurance central considerations.

Group Insights: Economic and Institutional Clusters Have Distinct Priorities

ASEAN markets generally prioritize scalable laboratory access, workforce development, and cost-conscious procurement across diverse health systems. BRICS economies combine substantial clinical demand with varied regulatory, reimbursement, manufacturing, and infrastructure conditions. The European Union emphasizes harmonized regulatory principles, laboratory quality, data protection, and cross-border health considerations. G7 systems typically focus on evidence-based use, advanced laboratory informatics, and equitable access. GCC countries are strengthening centralized and specialized healthcare services, while NATO members reflect diverse national procurement and screening policies despite shared interests in resilience, interoperability, and health-security preparedness.

Country Insights: National Systems Determine Testing Priorities

Australia and Canada emphasize guideline-based use across geographically dispersed healthcare systems. Brazil, Mexico, India, and South Africa face the combined priorities of expanding access, managing regional disparities, and strengthening laboratory quality. China, Japan, and South Korea have sophisticated diagnostic capabilities, with continued attention to automation, aging populations, and integrated care. France, Germany, Italy, Spain, and the United Kingdom operate within established European clinical and regulatory frameworks, while differing in screening policy, reimbursement, and laboratory organization. Russia’s testing environment is influenced by public-sector capacity, regional variation, and supply-chain resilience. In the United States, decentralized care delivery, insurance complexity, laboratory accreditation, and clinical appropriateness are particularly important.

Industry Leaders Should Prioritize Evidence, Interoperability, and Equitable Access

Leaders should align assay performance claims with intended use, applicable standards, and independently generated clinical evidence. They should strengthen lot-to-lot consistency, calibration traceability, internal quality controls, external proficiency testing, and transparent documentation. Investments in interoperable instruments and laboratory information systems can reduce manual errors and improve longitudinal interpretation. Organizations should also establish responsible AI governance, including bias testing, human oversight, privacy protections, and post-deployment monitoring. Regional strategies should account for reimbursement, procurement, service capacity, training, cold-chain or storage requirements, and continuity planning rather than relying on a single global operating model.

Research Methodology: Evidence-Based Assessment of the Diagnostic Environment

This executive summary uses the defined market scope-total PSA assay kits-and synthesizes the supplied geographic requirements with established diagnostic-market evaluation principles. Analysis considers clinical use, laboratory workflow, analytical quality, regulation, reimbursement, healthcare infrastructure, procurement, digital integration, and responsible AI adoption. Regional, group, and country observations are presented qualitatively and avoid market estimates, market shares, forecasts, company identification, and unsupported numerical claims. Conclusions should be validated against current national guidelines, regulatory records, laboratory standards, and peer-reviewed clinical evidence before operational decisions are made.

Conclusion: Reliable PSA Testing Depends on Contextual Clinical Integration

The strategic importance of total PSA assay kits rests on dependable analytical performance and their integration into responsible prostate-health pathways. Progress will depend on combining quality-assured assays with appropriate clinical interpretation, interoperable data systems, trained personnel, equitable access, and carefully governed AI. Organizations that connect product reliability with local policy, infrastructure, and patient-centered decision-making will be better positioned to support useful testing while limiting avoidable downstream procedures.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Total Prostate Specific Antigen Assay Kit Market, by Technology
7.1. Introduction
7.2. Chemiluminescent Immunoassay
7.3. Enzyme-Linked Immunosorbent Assay
7.4. Fluorescence Immunoassay
8. Total Prostate Specific Antigen Assay Kit Market, by Sample Type
8.1. Introduction
8.2. Plasma
8.3. Serum
8.4. Whole Blood
9. Total Prostate Specific Antigen Assay Kit Market, by Application
9.1. Introduction
9.2. Monitoring Treatment
9.3. Research
9.4. Screening
10. Total Prostate Specific Antigen Assay Kit Market, by End Use
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals
10.4. Research Institutes
11. Total Prostate Specific Antigen Assay Kit Market, by Sales Channel
11.1. Introduction
11.2. Direct Tender
11.3. Distributor
11.4. Online Retail
12. Total Prostate Specific Antigen Assay Kit Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Total Prostate Specific Antigen Assay Kit Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Total Prostate Specific Antigen Assay Kit Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Abcam plc
16.3. Beckman Coulter, Inc.
16.4. Bio-Rad Laboratories, Inc.
16.5. bioMérieux SA
16.6. DiaSorin S.p.A.
16.7. F. Hoffmann-La Roche Ltd
16.8. Ortho Clinical Diagnostics, Inc.
16.9. Quidel Corporation
16.10. Siemens Healthcare Diagnostics Inc.
16.11. Thermo Fisher Scientific Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Total Prostate Specific Antigen Assay Kit Market, Years Considered for the Study
FIGURE 2. Global Total Prostate Specific Antigen Assay Kit Market, Research Design
FIGURE 3. Global Total Prostate Specific Antigen Assay Kit Market, Research Framework
FIGURE 4. Global Total Prostate Specific Antigen Assay Kit Market, Data Triangulation
FIGURE 5. Global Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 9. Global Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2025 vs 2032 (%)
FIGURE 13. Global Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 15. Global Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Total Prostate Specific Antigen Assay Kit Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Total Prostate Specific Antigen Assay Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Total Prostate Specific Antigen Assay Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Total Prostate Specific Antigen Assay Kit Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Total Prostate Specific Antigen Assay Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Total Prostate Specific Antigen Assay Kit Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Total Prostate Specific Antigen Assay Kit Market Segmentation & Coverage
TABLE 2. Global Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 3. Global Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Chemiluminescent Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Chemiluminescent Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Chemiluminescent Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Enzyme-Linked Immunosorbent Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Enzyme-Linked Immunosorbent Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Enzyme-Linked Immunosorbent Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Fluorescence Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Fluorescence Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Fluorescence Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 14. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 24. Global Monitoring Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Monitoring Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Monitoring Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 34. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 44. Global Direct Tender Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Direct Tender Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Direct Tender Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Online Retail Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Online Retail Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Online Retail Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Total Prostate Specific Antigen Assay Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Total Prostate Specific Antigen Assay Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 60. North America Total Prostate Specific Antigen Assay Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. North America Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 62. North America Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 63. North America Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. North America Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 65. North America Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 66. Latin America Total Prostate Specific Antigen Assay Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Latin America Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 68. Latin America Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 69. Latin America Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 70. Latin America Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 71. Latin America Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 72. Europe Total Prostate Specific Antigen Assay Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Europe Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 74. Europe Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 75. Europe Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. Europe Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 77. Europe Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 78. Middle East Total Prostate Specific Antigen Assay Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Middle East Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 80. Middle East Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 81. Middle East Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. Middle East Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 83. Middle East Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 84. Africa Total Prostate Specific Antigen Assay Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Africa Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 86. Africa Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 87. Africa Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Africa Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 89. Africa Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 90. Global Total Prostate Specific Antigen Assay Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. ASEAN Total Prostate Specific Antigen Assay Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. ASEAN Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 93. ASEAN Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 94. ASEAN Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. ASEAN Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 96. ASEAN Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 97. GCC Total Prostate Specific Antigen Assay Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. GCC Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 99. GCC Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 100. GCC Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. GCC Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 102. GCC Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 103. European Union Total Prostate Specific Antigen Assay Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. European Union Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 105. European Union Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 106. European Union Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. European Union Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 108. European Union Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 109. BRICS Total Prostate Specific Antigen Assay Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. BRICS Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 111. BRICS Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 112. BRICS Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. BRICS Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 114. BRICS Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 115. G7 Total Prostate Specific Antigen Assay Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. G7 Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 117. G7 Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 118. G7 Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. G7 Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 120. G7 Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 121. NATO Total Prostate Specific Antigen Assay Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. NATO Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 123. NATO Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 124. NATO Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. NATO Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 126. NATO Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 127. Global Total Prostate Specific Antigen Assay Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. United States Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 129. United States Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 130. United States Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 131. United States Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. United States Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 133. United States Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 134. Canada Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 135. Canada Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 136. Canada Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 137. Canada Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Canada Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 139. Canada Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 140. Mexico Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 141. Mexico Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 142. Mexico Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 143. Mexico Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. Mexico Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 145. Mexico Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 146. Brazil Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 147. Brazil Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 148. Brazil Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 149. Brazil Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Brazil Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 151. Brazil Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 152. United Kingdom Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 153. United Kingdom Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. United Kingdom Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 155. United Kingdom Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. United Kingdom Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 157. United Kingdom Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 158. Germany Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 159. Germany Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 160. Germany Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 161. Germany Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Germany Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 163. Germany Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 164. France Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 165. France Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 166. France Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 167. France Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. France Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 169. France Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 170. Russia Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 171. Russia Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 172. Russia Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 173. Russia Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Russia Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 175. Russia Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 176. Italy Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 177. Italy Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 178. Italy Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 179. Italy Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. Italy Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 181. Italy Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 182. Spain Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 183. Spain Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. Spain Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 185. Spain Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Spain Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 187. Spain Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 188. China Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 189. China Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 190. China Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 191. China Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. China Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 193. China Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 194. India Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 195. India Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. India Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 197. India Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. India Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 199. India Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 200. Japan Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 201. Japan Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 202. Japan Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 203. Japan Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Japan Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 205. Japan Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 206. Australia Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 207. Australia Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Australia Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 209. Australia Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Australia Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 211. Australia Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 212. South Korea Total Prostate Specific Antigen Assay Kit Market Size, 2017-2032 (USD Million)
TABLE 213. South Korea Total Prostate Specific Antigen Assay Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 214. South Korea Total Prostate Specific Antigen Assay Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 215. South Korea Total Prostate Specific Antigen Assay Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. South Korea Total Prostate Specific Antigen Assay Kit Market Size, by End Use, 2017-2032 (USD Million)
TABLE 217. South Korea Total Prostate Specific Antigen Assay Kit Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 218. Global Total Prostate Specific Antigen Assay Kit Market Share, by Key Player, 2025
TABLE 219. Global Total Prostate Specific Antigen Assay Kit Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Abcam plc
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Ortho Clinical Diagnostics, Inc.
  • Quidel Corporation
  • Siemens Healthcare Diagnostics Inc.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Free Prostate-Specific Antigen Assay Kit Market - Global Forecast 2026-2032 - Product Image

Free Prostate-Specific Antigen Assay Kit Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Prostate Specific Antigen (PSA) Test Market Report 2026 - Product Image

Prostate Specific Antigen (PSA) Test Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Prostate-Specific Antigen Test Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Prostate-Specific Antigen Test Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 130 Pages
  • Global
From
Prostate-Specific Membrane Antigen Inhibitor Market - Global Forecast 2026-2032 - Product Image

Prostate-Specific Membrane Antigen Inhibitor Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Report 2026 - Product Image

Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.